Regarding this issue, Klein and Calderón tested the therapeutic outcomes of rapamycin on NPC disease progression in male Npc1−/− mice from C57BL6/J and FVB/NJ genetic backgrounds130. The gene discussed is NPC1; the disease is nasopharyngeal carcinoma.